Lazar Harold L, Ketchedjian Ara, Haime Miguel, Karlson Karl, Cabral Howard
Division of Cardiac Surgery, Boston Medical Center and the Boston University School of Medicine, Boston, Mass.
Division of Cardiac Surgery, Boston Medical Center and the Boston University School of Medicine, Boston, Mass.
J Thorac Cardiovasc Surg. 2014 Sep;148(3):1035-8; 1038-40. doi: 10.1016/j.jtcvs.2014.06.045. Epub 2014 Jul 2.
This study was undertaken to determine whether topical vancomycin would further reduce the incidence of sternal infections in the presence of perioperative antibiotics and tight glycemic control.
A total of 1075 consecutive patients undergoing cardiac surgery from December 2007 to August 2013 receiving topical vancomycin (2.5 g in 2 mL of normal saline) applied as a slurry to the cut edges of the sternum were compared with 2190 patients from December 2003 to November 2007 who did not receive topical vancomycin. All patients received perioperative antibiotics (cefazolin 2 g intravenously every 8 hours and vancomycin 1 g intravenously every 12 hours) on induction of anesthetic and continuing for 48 hours; and intravenous insulin infusions to maintain serum blood glucose level between 120 and 180 mg/dL.
Patients receiving topical vancomycin had less superficial sternal infections (0% vs 1.6%; P < .0001), deep sternal infections (0% vs 0.7%; P = .005), any type of sternal infection (0% vs 2.2%; P < .0001) and significantly less sternal infections of any type in patients with diabetes mellitus (0% vs 3.3%; P = .0004).
Topical vancomycin applied to the sternal edges, in conjunction with perioperative antibiotics and tight glycemic control, helps to eliminate wound infections in cardiac surgical patients.
本研究旨在确定在围手术期使用抗生素及严格控制血糖的情况下,局部应用万古霉素是否会进一步降低胸骨感染的发生率。
将2007年12月至2013年8月期间连续接受心脏手术并在胸骨切缘涂抹局部用万古霉素(2.5 g溶于2 mL生理盐水中制成糊剂)的1075例患者,与2003年12月至2007年11月期间未接受局部用万古霉素的2190例患者进行比较。所有患者在麻醉诱导时接受围手术期抗生素治疗(头孢唑林每8小时静脉注射2 g,万古霉素每12小时静脉注射1 g)并持续48小时;通过静脉输注胰岛素将血清血糖水平维持在120至180 mg/dL之间。
接受局部用万古霉素的患者浅表胸骨感染较少(0%对1.6%;P <.0001),深部胸骨感染较少(0%对0.7%;P =.005),任何类型的胸骨感染较少(0%对2.2%;P <.0001),糖尿病患者中任何类型的胸骨感染也显著较少(0%对3.3%;P =.0004)。
在胸骨边缘应用局部用万古霉素,联合围手术期抗生素及严格控制血糖,有助于消除心脏手术患者的伤口感染。